{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:26:41Z","timestamp":1788215201791,"version":"build-2803163510"},"reference-count":172,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.isci.2024.108783","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T09:11:05Z","timestamp":1704359465000},"page":"108783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome"],"prefix":"10.1016","volume":"27","author":[{"given":"Qiuyu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3154-8215","authenticated-orcid":false,"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2024.108783_bib1","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multi\u2013society Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib5","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.isci.2024.108783_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.aohep.2020.01.004","article-title":"Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population","volume":"19","author":"Salva-Pastor","year":"2020","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database","volume":"15","author":"Kumarendran","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.isci.2024.108783_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18314\/cogo.v1i1.999","article-title":"The Association of Hispanic Ethnicity with Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome","volume":"1","author":"Sarkar","year":"2018","journal-title":"Curr. Opin. Gynecol. Obstet."},{"key":"10.1016\/j.isci.2024.108783_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-019-02085-7","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"67","author":"Paschou","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.isci.2024.108783_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","author":"Vassilatou","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12916-023-02775-0","article-title":"The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome","volume":"21","author":"Liu","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.isci.2024.108783_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12020-015-0640-8","article-title":"Evidence that non-alcoholic fatty liver disease and polycystic ovary syndrome are associated by necessity rather than chance: a novel hepato-ovarian axis?","volume":"51","author":"Targher","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.isci.2024.108783_bib13","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","author":"Hagstr\u00f6m","year":"2023","journal-title":"J.\u00a0Hepatol"},{"key":"10.1016\/j.isci.2024.108783_bib14","article-title":"Can we use old NAFLD data under the new MASLD definition?","author":"Song","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.isci.2024.108783_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.isci.2024.108783_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40618-020-01351-0","article-title":"Insulin resistance and PCOS: chicken or egg?","volume":"44","author":"Moghetti","year":"2021","journal-title":"J.\u00a0Endocrinol. Invest."},{"key":"10.1016\/j.isci.2024.108783_bib18","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1172\/JCI86013","article-title":"Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance","volume":"126","author":"Petersen","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2024.108783_bib19","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.108783_bib20","first-page":"653","article-title":"Associations of insulin resistance, sex hormone-binding globulin, triglyceride, and hormonal profiles in polycystic ovary syndrome: A cross-sectional study","volume":"19","author":"Jahromi","year":"2021","journal-title":"Int. J. Reprod. Biomed."},{"key":"10.1016\/j.isci.2024.108783_bib21","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and Characteristics of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib22","doi-asserted-by":"crossref","first-page":"E1047","DOI":"10.1152\/ajpendo.00361.2004","article-title":"Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling","volume":"288","author":"Corbould","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib23","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41401-021-00836-9","article-title":"GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis","volume":"43","author":"Chen","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.isci.2024.108783_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","article-title":"Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease","volume":"52","author":"Makri","year":"2021","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.isci.2024.108783_bib25","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults","volume":"20","author":"Liu","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.isci.2024.108783_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCULATIONAHA.107.739920","article-title":"Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease","volume":"118","author":"Schwimmer","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.isci.2024.108783_bib28","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1038\/s41467-020-19003-5","article-title":"Defining the impact of dietary macronutrient balance on PCOS traits","volume":"11","author":"Rodriguez Paris","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.108783_bib29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jc.2008-2648","article-title":"Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women","volume":"94","author":"Robker","year":"2009","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib30","first-page":"E89","article-title":"The Mechanism of Androgen Actions in PCOS Etiology","volume":"7","author":"Rodriguez Paris","year":"2019","journal-title":"Med. Sci."},{"key":"10.1016\/j.isci.2024.108783_bib31","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/children9111748","article-title":"Sex Hormone-Binding Globulin (SHBG) Reduction: The Alarm Bell for the Risk of Non-Alcoholic Fatty Liver Disease in Adolescents with Polycystic Ovary Syndrome","volume":"9","author":"Urbano","year":"2022","journal-title":"Children"},{"key":"10.1016\/j.isci.2024.108783_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12986-018-0313-8","article-title":"Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults","volume":"15","author":"Luo","year":"2018","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib33","doi-asserted-by":"crossref","first-page":"dgz244","DOI":"10.1210\/clinem\/dgz244","article-title":"Serum SHBG Is Associated With the Development and Regression of Nonalcoholic Fatty Liver Disease: A Prospective Study","volume":"105","author":"Wang","year":"2020","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/cen.12360","article-title":"Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients","volume":"80","author":"Hua","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/09513590.2017.1411474","article-title":"SHBG expression is correlated with PI3K\/AKT pathway activity in a cellular model of human insulin resistance","volume":"34","author":"Feng","year":"2018","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygcen.2017.12.007","article-title":"Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - Clinical based case control study","volume":"260","author":"Malini","year":"2018","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13679-012-0027-6","article-title":"Obesity and the Endocannabinoid System: Circulating Endocannabinoids and Obesity","volume":"1","author":"Matias","year":"2012","journal-title":"Curr. Obes. Rep."},{"key":"10.1016\/j.isci.2024.108783_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/09513590.2014.946899","article-title":"Selected CNR1 polymorphisms and hyperandrogenemia as well as fat mass and fat distribution in women with polycystic ovary syndrome","volume":"31","author":"J\u0119drzejuk","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/232975","article-title":"Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls","volume":"2014","author":"Kuliczkowska Plaksej","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12902-017-0194-2","article-title":"Endocannabinoid receptor blockade reduces alanine aminotransferase in polycystic ovary syndrome independent of weight loss","volume":"17","author":"Dawson","year":"2017","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.isci.2024.108783_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025261","article-title":"Early hypothalamic FTO overexpression in response to maternal obesity--potential contribution to postweaning hyperphagia","volume":"6","author":"Caruso","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.108783_bib42","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ng.713","article-title":"Overexpression of Fto leads to increased food intake and results in obesity","volume":"42","author":"Church","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2024.108783_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003166","article-title":"Adult onset global loss of the fto gene alters body composition and metabolism in the mouse","volume":"9","author":"McMurray","year":"2013","journal-title":"PLoS Genet."},{"key":"10.1016\/j.isci.2024.108783_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12881-017-0452-1","article-title":"Association between fat mass and obesity associated (FTO) gene rs9939609 A\/T polymorphism and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Liu","year":"2017","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.isci.2024.108783_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2350-11-12","article-title":"Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS)","volume":"11","author":"Tan","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.isci.2024.108783_bib46","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1007\/s00125-012-2638-6","article-title":"Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"55","author":"Wojciechowski","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.isci.2024.108783_bib47","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.29273","article-title":"The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation","volume":"66","author":"BasuRay","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.108783_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.15403\/jgld-506","article-title":"PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes","volume":"28","author":"Karamfilova","year":"2019","journal-title":"J.\u00a0Gastrointestin. Liver Dis."},{"key":"10.1016\/j.isci.2024.108783_bib49","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1136\/gutjnl-2019-319226","article-title":"Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker","volume":"69","author":"Baselli","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.isci.2024.108783_bib50","first-page":"5212","article-title":"PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis","volume":"25","author":"Pingitore","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2024.108783_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234465","article-title":"Gene polymorphisms of Patatin-like phospholipase domain containing 3 (PNPLA3), adiponectin, leptin in diabetic obese patients","volume":"15","author":"Aly","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.108783_bib52","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1038\/s41591-023-02553-8","article-title":"Interaction between estrogen receptor-\u03b1 and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women","volume":"29","author":"Cherubini","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.108783_bib53","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/jdi.12792","article-title":"Angiopoietin-like protein 8\/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non-alcoholic fatty liver disease patients","volume":"9","author":"Hong","year":"2018","journal-title":"J.\u00a0Diabetes Investig."},{"key":"10.1016\/j.isci.2024.108783_bib54","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1038\/srep05013","article-title":"Elevated circulating lipasin\/betatrophin in human type 2 diabetes and obesity","volume":"4","author":"Fu","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2024.108783_bib55","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1194\/jlr.M082099","article-title":"CRISPR\/Cas9-mediated Angptl8 knockout suppresses plasma triglyceride concentrations and adiposity in rats","volume":"59","author":"Izumi","year":"2018","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.isci.2024.108783_bib56","doi-asserted-by":"crossref","first-page":"96604","DOI":"10.18632\/oncotarget.21852","article-title":"Circulating betatrophin is associated with insulin resistance in humans: cross-sectional and interventional studies in\u00a0vivo and in\u00a0vitro","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2024.108783_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101152","article-title":"FGF19 and FGF21: In NASH we trust","volume":"46","author":"Talukdar","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib58","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1210\/jc.2012-1221","article-title":"Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis","volume":"97","author":"Reinehr","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/JOE-15-0136","article-title":"Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21","volume":"226","author":"Camporez","year":"2015","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib60","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2024.108783_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.568500","article-title":"Dynamic Changes in Circulating Endocrine FGF19 Subfamily and Fetuin-A in Response to Intralipid and Insulin Infusions in Healthy and PCOS Women","volume":"11","author":"Ramanjaneya","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib62","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/00365513.2014.900821","article-title":"Fibroblast growth factor 21 and its relation to metabolic parameters in women with polycystic ovary syndrome","volume":"74","author":"Sahin","year":"2014","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.isci.2024.108783_bib63","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-17-1053","article-title":"Association of fetuin-A with incident type 2 diabetes: results from the MONICA\/KORA Augsburg study and a systematic meta-analysis","volume":"178","author":"Sujana","year":"2018","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib64","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1515\/jpem-2020-0524","article-title":"Evaluation of the pathophysiological role of Fetuin A levels in adolescents with polycystic ovary syndrome","volume":"34","author":"Bayramo\u011flu","year":"2021","journal-title":"J.\u00a0Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib65","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.108783_bib66","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1210\/en.2011-2043","article-title":"Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance","volume":"153","author":"Ou","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2024.108783_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4192940","article-title":"Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome","volume":"2018","author":"D\u00edaz","year":"2018","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib68","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.diabet.2018.02.003","article-title":"Plasma fetuin-B concentrations are associated with insulin resistance and first-phase glucose-stimulated insulin secretion in individuals with different degrees of glucose tolerance","volume":"44","author":"Qu","year":"2018","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.isci.2024.108783_bib69","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2483435","article-title":"Elevated Circulating Fetuin-B Levels Are Associated with Insulin Resistance and Reduced by GLP-1RA in Newly Diagnosed PCOS Women","volume":"2020","author":"Mokou","year":"2020","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.isci.2024.108783_bib70","article-title":"Inhibition of HMGB1 protects the retina from ischemia-reperfusion, as well as reduces insulin resistance proteins","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.108783_bib71","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.24552","article-title":"Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.108783_bib72","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1096\/fj.202000605RR","article-title":"HMGB1-induced aberrant autophagy contributes to insulin resistance in granulosa cells in PCOS","volume":"34","author":"Zhang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.isci.2024.108783_bib73","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.4161\/auto.32184","article-title":"HMGB1-dependent and -independent autophagy","volume":"10","author":"Sun","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.isci.2024.108783_bib74","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","article-title":"Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease","volume":"6","author":"Baumeier","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib75","doi-asserted-by":"crossref","DOI":"10.1177\/2042018821989238","article-title":"The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence","volume":"12","author":"Abdalla","year":"2021","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4093\/dmj.2013.37.1.63","article-title":"Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease","volume":"37","author":"Choi","year":"2013","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.isci.2024.108783_bib77","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41467-017-01863-z","article-title":"Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models","volume":"8","author":"Mita","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2024.108783_bib78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41387-021-00170-3","article-title":"Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD","volume":"11","author":"Bilson","year":"2021","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.isci.2024.108783_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102322","article-title":"Overexpression of NAG-1\/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation","volume":"52","author":"Wang","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.isci.2024.108783_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.988767","article-title":"Arachidonic Acid in Follicular Fluid of PCOS Induces Oxidative Stress in a Human Ovarian Granulosa Tumor Cell Line (KGN) and Upregulates GDF15 Expression as a Response","volume":"13","author":"Ma","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib81","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib82","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2010.11.036","article-title":"CIRCULATING INFLAMMATORY MARKERS IN POLYCYSTIC OVARY SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.isci.2024.108783_bib83","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2265.2012.04454.x","article-title":"Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance","volume":"78","author":"Phelan","year":"2013","journal-title":"Clin. Endocrinol."},{"issue":"Pt 3","key":"10.1016\/j.isci.2024.108783_bib84","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1042\/BST0360340","article-title":"Macrophages, cytokines and beta-cell death in Type 2 diabetes","volume":"36","author":"Ehses","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.isci.2024.108783_bib85","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.3390\/ijms22073789","article-title":"Chronic Low Grade Inflammation in Pathogenesis of PCOS","volume":"22","author":"Rudnicka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.108783_bib86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-\u03b2 and NF-\u03baB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.108783_bib87","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.ijo.0802501","article-title":"Inflammation and the IKK beta\/I kappa B\/NF-kappa B axis in obesity- and diet-induced insulin resistance","volume":"27","author":"Shoelson","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.isci.2024.108783_bib88","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.108783_bib89","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1007\/s00394-018-1748-4","article-title":"Lack of liver steatosis in germ-free mice following hypercaloric diets","volume":"58","author":"Kaden-Volynets","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.isci.2024.108783_bib90","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.chom.2018.03.011","article-title":"Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids","volume":"23","author":"Martinez-Guryn","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2024.108783_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168390","article-title":"Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study","volume":"12","author":"Lindheim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2024.108783_bib92","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1210\/en.2019-00050","article-title":"Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model","volume":"160","author":"Torres","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.isci.2024.108783_bib93","article-title":"Gut microbiota\u2013mitochondrial inter-talk in non-alcoholic fatty liver disease","volume":"9","author":"Zhang","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.isci.2024.108783_bib94","doi-asserted-by":"crossref","first-page":"E1220","DOI":"10.3390\/nu9111220","article-title":"Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis","volume":"9","author":"Chiu","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2024.108783_bib95","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3389\/fmicb.2018.01602","article-title":"Genetically Obese Human Gut Microbiota Induces Liver Steatosis in Germ-Free Mice Fed on Normal Diet","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.108783_bib96","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2024.108783_bib97","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet\u2013Induced Obesity and Diabetes in Mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.isci.2024.108783_bib98","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.cell.2022.08.005","article-title":"Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome","volume":"185","author":"Kawano","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.108783_bib99","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.isci.2024.108783_bib100","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coemr.2020.04.005","article-title":"Abnormal GnRH Pulsatility in Polycystic Ovary Syndrome: Recent Insights","volume":"12","author":"McCartney","year":"2020","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"10.1016\/j.isci.2024.108783_bib101","doi-asserted-by":"crossref","first-page":"64","DOI":"10.14715\/cmb\/2017.63.10.10","article-title":"Hyperandrogenism stimulates inflammation and promote apoptosis of cumulus cells","volume":"63","author":"Xu","year":"2017","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.isci.2024.108783_bib102","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib103","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.18632\/oncotarget.24190","article-title":"Dehydroepiandrosterone-induced activation of mTORC1 and inhibition of autophagy contribute to skeletal muscle insulin resistance in a mouse model of polycystic ovary syndrome","volume":"9","author":"Song","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.isci.2024.108783_bib104","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/JOE-21-0040","article-title":"DHT causes liver steatosis via transcriptional regulation of SCAP in normal weight female mice","volume":"250","author":"Seidu","year":"2021","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib105","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jhep.2018.01.019","article-title":"Fructose and sugar: A major mediator of non-alcoholic fatty liver disease","volume":"68","author":"Jensen","year":"2018","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib106","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/09513590.2017.1405931","article-title":"The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"34","author":"Hu","year":"2018","journal-title":"Gynecol. Endocrinol."},{"issue":"2 pt 1","key":"10.1016\/j.isci.2024.108783_bib107","first-page":"261","article-title":"Subclinical hypothyroidism in patients with non-alcoholic fatty liver disease at the background of carbohydrate metabolism disorders","volume":"71","author":"Feisa","year":"2018","journal-title":"Wiad. Lek."},{"key":"10.1016\/j.isci.2024.108783_bib108","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2230-8210.146860","article-title":"Thyroid disorders and polycystic ovary syndrome: An emerging relationship","volume":"19","author":"Singla","year":"2015","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib109","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ijgo.13581","article-title":"Thyroid-stimulating hormone level is negatively associated with fertilization rate in patients with polycystic ovary syndrome undergoing in\u00a0vitro fertilization","volume":"155","author":"Gao","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.isci.2024.108783_bib110","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.14309\/ajg.0000000000000654","article-title":"Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality","volume":"115","author":"Kim","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.isci.2024.108783_bib111","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2024.108783_bib112","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12967-021-02817-2","article-title":"Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome","volume":"19","author":"Li","year":"2021","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.isci.2024.108783_bib113","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/advances\/nmaa092","article-title":"Effects of Dietary Glycemic Index and Glycemic Load on Cardiometabolic and Reproductive Profiles in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials","volume":"12","author":"Kazemi","year":"2021","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.isci.2024.108783_bib114","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.fertnstert.2014.01.036","article-title":"A retrospective cohort study to evaluate the impact of meaningful weight loss on fertility outcomes in an overweight population with infertility","volume":"101","author":"Kort","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.isci.2024.108783_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/nu12041066","article-title":"Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases","volume":"12","author":"Mirabelli","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2024.108783_bib116","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s40279-016-0669-8","article-title":"Effect of Exercise on Ovulation: A Systematic Review","volume":"47","author":"Hakimi","year":"2017","journal-title":"Sports Med."},{"key":"10.1016\/j.isci.2024.108783_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118868","article-title":"Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-\u03b1 signaling in obese mice","volume":"266","author":"Diniz","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.isci.2024.108783_bib118","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cmet.2022.12.001","article-title":"Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial","volume":"35","author":"Ezpeleta","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2024.108783_bib119","doi-asserted-by":"crossref","first-page":"e14461","DOI":"10.1111\/jfbc.14461","article-title":"Dietary tea seed saponin combined with aerobic exercise attenuated lipid metabolism and oxidative stress in mice fed a high-fat diet (HFD)","volume":"46","author":"Cao","year":"2022","journal-title":"J.\u00a0Food Biochem."},{"key":"10.1016\/j.isci.2024.108783_bib120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2009.03.016","article-title":"Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.isci.2024.108783_bib121","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmet.2016.09.003","article-title":"Metformin Activates AMPK through the Lysosomal Pathway","volume":"24","author":"Zhang","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2024.108783_bib122","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","article-title":"Metformin Inhibits Hepatic mTORC1 Signaling via Dose-Dependent Mechanisms Involving AMPK and the TSC Complex","volume":"25","author":"Howell","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2024.108783_bib123","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","article-title":"AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice","volume":"13","author":"Li","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.isci.2024.108783_bib124","doi-asserted-by":"crossref","first-page":"E1099","DOI":"10.1152\/ajpendo.00417.2013","article-title":"Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle","volume":"306","author":"Kristensen","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib125","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","article-title":"Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2024.108783_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1000144","article-title":"Metformin modulates the gut microbiome in broiler breeder hens","volume":"13","author":"Van Syoc","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.isci.2024.108783_bib127","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11995","article-title":"Association of Metformin With Pregnancy Outcomes in Women With Polycystic Ovarian Syndrome Undergoing In\u00a0Vitro Fertilization: A Systematic Review and Meta-analysis","volume":"3","author":"Wu","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.isci.2024.108783_bib128","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3389\/fphar.2020.00653","article-title":"Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function","volume":"11","author":"Jorquera","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2024.108783_bib129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/15548627.2014.984271","article-title":"Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway","volume":"11","author":"Song","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.isci.2024.108783_bib130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.5009\/gnl20367","article-title":"Effects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels","volume":"15","author":"Pinyopornpanish","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.isci.2024.108783_bib131","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jhep.2018.11.034","article-title":"Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish","volume":"70","author":"de Oliveira","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib132","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.3390\/ijms22095016","article-title":"Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.108783_bib133","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/17512433.2021.1933433","article-title":"Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome","volume":"14","author":"Siamashvili","year":"2021","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.isci.2024.108783_bib134","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/clinem\/dgab578","article-title":"The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD","volume":"107","author":"Patel Chavez","year":"2022","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib135","doi-asserted-by":"crossref","first-page":"e2695","DOI":"10.1210\/clinem\/dgaa285","article-title":"Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists","volume":"105","author":"Cena","year":"2020","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib136","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.molmet.2014.09.005","article-title":"GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance","volume":"3","author":"Taher","year":"2014","journal-title":"Mol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib137","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/hep.30670","article-title":"Incretin-Based Therapies for the Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes","volume":"69","author":"Cusi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.108783_bib138","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/07435800.2014.966385","article-title":"Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome","volume":"40","author":"Jensterle","year":"2015","journal-title":"Endocr. Res."},{"key":"10.1016\/j.isci.2024.108783_bib139","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2024.108783_bib140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tem.2022.03.005","article-title":"SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease","volume":"33","author":"Moon","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib141","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4158\/EP-2017-0027","article-title":"DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY","volume":"24","author":"Ferjan","year":"2018","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.isci.2024.108783_bib142","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/clinem\/dgz028","article-title":"Sitagliptin Decreases Visceral Fat and Blood Glucose in Women With Polycystic Ovarian Syndrome","volume":"105","author":"Devin","year":"2020","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21217815","article-title":"Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor","volume":"21","author":"Okuyama","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2024.108783_bib144","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cbi.2017.06.009","article-title":"The promising effect of linagliptin and\/or indole-3-carbinol on experimentally-induced polycystic ovarian syndrome","volume":"273","author":"Kabel","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.isci.2024.108783_bib145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4419-9072-3_22","article-title":"A paradigm for gene regulation: inflammation, NF-kappaB and PPAR","volume":"544","author":"Vanden Berghe","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.isci.2024.108783_bib146","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.7150\/ijms.37677","article-title":"PPAR \u03b4 inhibition protects against palmitic acid-LPS induced lipidosis and injury in cultured hepatocyte L02 cell","volume":"16","author":"Li","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.isci.2024.108783_bib147","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/dom.12101","article-title":"Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?","volume":"15","author":"Consoli","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib148","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00380-018-1143-3","article-title":"Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial","volume":"33","author":"Tanaka","year":"2018","journal-title":"Heart Ves."},{"key":"10.1016\/j.isci.2024.108783_bib149","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/liv.14350","article-title":"A diabetologist\u2019s perspective of non-alcoholic steatohepatitis (NASH): Knowledge gaps and future directions","volume":"40","author":"Cusi","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.isci.2024.108783_bib150","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3748\/wjg.v28.i17.1814","article-title":"Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice","volume":"28","author":"Silva-Veiga","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.isci.2024.108783_bib151","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/14656566.2018.1494727","article-title":"Understanding the impact of commonly utilized, non-insulin, glucose-lowering drugs on body weight in patients with type 2 diabetes","volume":"19","author":"Hurren","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.isci.2024.108783_bib152","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s12325-012-0044-6","article-title":"Effects of thiazolidinediones on polycystic ovary syndrome: a meta-analysis of randomized placebo-controlled trials","volume":"29","author":"Du","year":"2012","journal-title":"Adv. Ther."},{"key":"10.1016\/j.isci.2024.108783_bib153","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00404-017-4480-z","article-title":"Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis","volume":"296","author":"Xu","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.isci.2024.108783_bib154","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","article-title":"Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"58","author":"Staels","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.isci.2024.108783_bib155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/13543784.2020.1668375","article-title":"Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)","volume":"29","author":"Westerouen Van Meeteren","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.isci.2024.108783_bib156","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2337\/dc18-0165","article-title":"Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)","volume":"41","author":"Kuchay","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.isci.2024.108783_bib157","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jceh.2015.02.005","article-title":"Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice","volume":"5","author":"Nakano","year":"2015","journal-title":"J.\u00a0Clin. Exp. Hepatol."},{"key":"10.1016\/j.isci.2024.108783_bib158","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1152\/ajprenal.00518.2013","article-title":"Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia","volume":"306","author":"Rieg","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.isci.2024.108783_bib159","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/cen.13968","article-title":"Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: A randomized controlled study","volume":"90","author":"Javed","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib160","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/jcb.30327","article-title":"New insights into cellular links between sodium-glucose cotransporter-2 inhibitors and ketogenesis","volume":"123","author":"Yaribeygi","year":"2022","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.isci.2024.108783_bib161","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1210\/jc.2009-0870","article-title":"Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy","volume":"94","author":"Cussons","year":"2009","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.isci.2024.108783_bib162","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/iub.1991","article-title":"Role of vitamin E in nonalcoholic fatty liver disease","volume":"71","author":"Nagashimada","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.isci.2024.108783_bib163","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.mce.2016.09.008","article-title":"The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome","volume":"439","author":"Rahmani","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.isci.2024.108783_bib164","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-0042-117773","article-title":"The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"125","author":"Ebrahimi","year":"2017","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.isci.2024.108783_bib165","first-page":"556","article-title":"Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome","volume":"27","author":"Borzoei","year":"2018","journal-title":"Asia Pac. J. Clin. Nutr."},{"key":"10.1016\/j.isci.2024.108783_bib166","doi-asserted-by":"crossref","first-page":"E188","DOI":"10.3390\/nu11010188","article-title":"A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome","volume":"11","author":"Javed","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.isci.2024.108783_bib167","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.soard.2019.03.032","article-title":"Effects of bariatric surgery on obese polycystic ovary syndrome: a systematic review and meta-analysis","volume":"15","author":"Li","year":"2019","journal-title":"Surg. Obes. Relat. Dis."},{"key":"10.1016\/j.isci.2024.108783_bib168","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.isci.2024.108783_bib169","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.3390\/jcm10245721","article-title":"Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric\/Metabolic Surgery as Its Treatment Option: A Review","volume":"10","author":"G\u0142uszy\u0144ska","year":"2021","journal-title":"J.\u00a0Clin. Med."},{"key":"10.1016\/j.isci.2024.108783_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1003755","article-title":"Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality","volume":"13","author":"Xia","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2024.108783_bib171","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1570161115666170621082910","article-title":"Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk","volume":"16","author":"Athyros","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.isci.2024.108783_bib172","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.903856","article-title":"Regulation of lipid droplet (LD) formation in hepatocytes via regulation of SREBP1c by non-coding RNAs","volume":"9","author":"El Sobky","year":"2022","journal-title":"Front. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422400004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258900422400004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T04:23:30Z","timestamp":1739679810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258900422400004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":172,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S258900422400004X"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2024.108783","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2024.108783","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"108783"}}